Main content
Sorry, this episode is not currently available

A Risk Worth Taking?

Shelley Jofre investigates the drug Avandia and asks whether the medicine's regulator is putting the interests of the drugs industry before patients.

We're in the grip of a diabetes epidemic. The NHS spent more than half a billion pounds on medication for it in 2009. Patients trust that these drugs are safe, but does one come with a hidden cost to health? Shelley Jofre investigates the rise and fall of Avandia, until recently one of the UK's best-selling diabetes drugs, and asks whether the medicine's regulator is putting the interests of the drugs industry before patients.

29 minutes

Last on

Sun 12 Sep 2010 20:30

Credits

Role Contributor
Presenter Jeremy Vine
Producer Angie Mason
Reporter Shelley Jofre

Broadcasts

  • Mon 6 Sep 2010 20:30
  • Thu 9 Sep 2010 04:30
  • Fri 10 Sep 2010 01:00
  • Fri 10 Sep 2010 01:55
  • Sat 11 Sep 2010 00:50
  • Sun 12 Sep 2010 20:30

Explore the wider challenges that people with a learning disability face in society, and how this impacts on their health

Explore the wider challenges that people with a learning disability face in society, and how this impacts on their health

Find out more with The Open University.